DENTSPLY SIRONA's fair value estimate has seen a modest decrease, from $16.21 to $16.00 per share. This reflects recent market reassessments. In addition, the stock's discount rate rose slightly, ...

The company revised its 2025 outlook, now projecting net sales in the range of $3.6 billion to $3.7 billion with constant currency sales expected to be between negative 5% and negative 4% ...

Dentsply Sirona Inc. (NASDAQ:XRAY) stock is trading lower on Thursday after weaker-than-expected third-quarter earnings and lowered guidance. • XRAY shares are approaching critical lows. Get the ...

Dentsply Sirona Inc. (NASDAQ:XRAY) announced Wednesday that Matthew E. Garth will no longer serve as Executive Vice President and Chief Financial Officer, effective the same day. The company has begun ...

Dental products company Dentsply Sirona (NASDAQ:XRAY) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 4.9% year on year to $904 million. The company expects the ...

Dentsply Sirona shares gained after the Securities and Exchange Commission concluded its investigation of the company. The stock rose 7% to $13.30 in after-hours trading Tuesday. Through the close, ...

Dentsply Sirona released preliminary financial results for the second quarter that would have it coming in at or above Wall Street projections. The maker of professional dental products and technology ...

We independently review everything we recommend. We may get paid to link out to retailer sites, and when you buy through our links, we may earn a commission. Learn more› By Rose Maura Lorre Rose Maura ...

In the last three months, 9 analysts have published ratings on Dentsply Sirona (NASDAQ:XRAY), offering a diverse range of perspectives from bullish to bearish. The table below provides a concise ...

Plans for the long-vacant former Dentsply campus in York City are beginning to take shape as developers bring a proposed townhouse development to the Zoning Hearing Board on Thursday night. The ...